Credit funds and private capital

Credit funds have become the most important capital source for emerging and middle-market ABF originators. They’re faster than banks, more flexible than insurance, and willing to take risks that traditional capital won’t touch. They’re also more expensive and more aggressive on terms. This topic covers how to evaluate whether a fund is right for your deal, what they’re actually looking for, and how to work with them effectively.

Is a fund the right fit for your deal?

Before you spend three months in a fund’s diligence process, run this quick assessment:

Fund lifecycle trumps everything. A fund in Years 1-2 of deployment is actively hunting deals. They need to put capital to work, and they’re motivated to close. A fund in Year 5-6 is managing their portfolio, preparing for exits, and thinking about the next fundraise. They might look at your deal but won’t prioritize it. Ask directly: “Where are you in your fund cycle?”

Mandate constraints are non-negotiable. If their LP agreement says “no consumer unsecured” or “investment-grade only,” no relationship will change that. Get the mandate parameters early:

Asset class restrictions
Minimum credit quality / rating requirements
Geographic limits
Single-name and sector concentration caps
Minimum and maximum check sizes

Prior ABF experience separates real partners from tourists. A fund that’s done 20 warehouse deals knows the diligence process, understands the documentation, and knows what breaks deals. A fund “looking to build ABF exposure” will take twice as long and ask basic questions in front of their IC. Ask: “How many ABF deals have you closed in this structure type in the last 24 months?”

Lead vs. participate matters. Some funds only participate in syndicated deals; they won’t anchor your warehouse. Others only lead and won’t take a minority position. Know what you need and whether they can provide it.

Assess key person risk. If one person is the ABF expert at the fund and they leave, your relationship may reset. Look at the depth of the team, not just your primary contact.

Screening Questions to Ask Early:

What’s your fund vintage and where are you in deployment?

What are your LP mandate constraints?

How many ABF deals (same structure type) have you closed in the last 24 months?

Who’s the IC sponsor and who else touches ABF at your firm?

What’s your typical hold size and do you lead or participate?

Types of credit funds in ABF

Not all credit funds are the same. Understanding the different types helps you target the right conversations.

Specialty finance funds

These funds focus specifically on ABF and asset-backed lending. They have deep asset class expertise (often staffed by former bank warehouse lenders), move faster through diligence, and can structure more sophisticated deals.

What they offer:

Faster diligence (they’ve seen your asset class before)
More creative structuring
Willing to take calculated risks on newer originators
Often position as “bridge to bank” capital

Typical return targets: 12-18% gross IRR

Active players: Waterfall Asset Management, Victory Park Capital, Castlelake, Monroe Capital, Atalaya Capital, Stellus Capital

Direct lending / private credit funds

These are large-scale private credit platforms where ABF is one allocation bucket among many (corporate direct lending, real estate debt, etc.). They can write bigger checks but may require more education on your specific asset class.

What they offer:

Larger commitment sizes ($100M-500M+)
Institutional infrastructure and stability
May take senior tranches at tighter spreads

What to expect:

Longer approval timelines (more committees, more stakeholders)
Broader IC audience that may not know ABF well
More standardized terms (less flexibility)

Typical return targets: 10-14% gross IRR (lower for senior tranches)

Active players: Ares Management, Apollo Global Management, Blue Owl Capital, HPS Investment Partners, Golub Capital, KKR Credit

Insurance-affiliated asset managers

These managers deploy insurance company capital, which comes with specific requirements: rated notes, investment-grade tranches, NAIC-efficient structures. They’re a hybrid between credit funds and direct insurance placement.

What they offer:

Very stable, long-term capital
Can take large positions in senior tranches
Tighter spreads than pure credit funds

What they require:

Rated notes (typically BBB- or better)
NAIC-compliant structures
Longer timelines (rating process, allocation committee)

Active players: BlackRock, PIMCO, Nuveen, MetLife Investment Management

Multi-strategy / opportunistic funds

These funds have flexible mandates and can move anywhere in the capital structure. They prefer equity-like returns (15%+) and gravitate toward complex or distressed situations.

What they offer:

Speed and flexibility
Willingness to do bespoke structures
May provide growth capital alongside debt

What to expect:

More aggressive terms
Shorter hold periods
May push for equity participation or warrants

What credit funds look for

Funds evaluate three things: you (the originator), your collateral, and the deal structure. Here’s how they weight them.

Originator quality (50% of the decision)

Credit funds are lending to you, secured by your collateral. If you fail, the collateral is their recovery. So they spend as much time on you as on the assets.

Management team: They want experienced operators who’ve been through cycles. Prior exits, skin in the game (personal investment in the business), and ABF experience all matter. If your management team is all first-time operators, expect more scrutiny.

Financial condition: They’ll stress test whether you can survive a performance downturn. Key metrics:

Tangible net worth (typically 5-10% of facility size as a floor)
Liquidity runway (12+ months of operating expenses)
Clean audit (qualified opinions are deal-killers)
Manageable corporate leverage

Operational infrastructure: Can you actually service what you originate? They’ll evaluate:

Servicing systems and capabilities
Reporting infrastructure
Compliance and licensing
Backup servicer arrangements

Data quality: A messy loan tape signals operational problems. They want:

Complete loan-level data with data dictionary
Static pool history (ideally 3+ years by vintage)
Consistent field definitions across vintages
Minimal missing or erroneous data

Collateral quality (30% of the decision)

Once they’re comfortable with you, they turn to the assets.

Historical performance: CNL, CDR, severity by vintage. They’ll benchmark you against:

Your own prior vintages (are you consistent or deteriorating?)
Public ABS comparables (how do you stack up?)
Rating agency assumptions for your asset class

Portfolio composition: They’ll stratify your tape and look for:

Concentration risk (geography, employer, credit score bands)
Seasoning distribution
Credit quality distribution vs. your stated guidelines

Underwriting standards: Have your guidelines been consistent, or have you drifted? Guideline drift (“creeping credit box”) is a red flag that signals desperation for volume.

Deal structure (20% of the decision)

The structure protects them if things go wrong.

Advance rate: Is it appropriate for the asset class and your track record? Too aggressive and there’s no cushion.

Covenants: They want covenants tight enough to give early warning but not so tight they trip in normal volatility.

True sale and perfection: Non-negotiable. If the assets aren’t cleanly transferred and perfected, they have no security.

Servicing: Are you servicing or is a third party? What’s the backup plan?

Return targets and your pricing floor

Understanding the fund’s math helps you calibrate your expectations.

The fund economics

A typical specialty finance fund operates like this:

Gross IRR target: 14-17%
Management fee: 1.25-1.5% annually on committed capital
Performance fee (carry): 20% over an 8% hurdle
GP commit: 2-5% of fund size

After fees, LPs might net 10-13% if the fund hits its gross target. The fund needs every deal to contribute to that gross number.

How this translates to your deal

If a fund targets 15% gross and your deal doesn’t clear that hurdle, they won’t tell you directly. They’ll find other reasons to pass or drag the process.

Here’s the simplified math for a warehouse:

Fund targets 15% gross return
Needs ~13% yield on deployed capital (accounting for uninvested commitments, ramp time)
Your 85% advance rate warehouse needs to generate spread + fees that clear this

Result: Specialty finance funds typically price warehouses at SOFR + 300-450 bps, plus upfront fees (50-100 bps) and commitment fees (25-50 bps on undrawn). All-in, you’re looking at an effective rate of SOFR + 350-500+ bps.

Compare this to a bank, which might price the same senior warehouse at SOFR + 175-250 bps. The fund is more expensive, but they’ll do deals banks won’t touch.

What high return targets mean for you

Funds with higher return targets (15%+ gross) may push for:

Warrants or equity co-invest
Profit participation or excess spread sharing
Board observer rights
Lower advance rates (to juice their returns through leverage)

If you see these requests, you’re talking to a fund that needs more yield than pure spread provides.

Ask Directly: “What’s your minimum return threshold for a deal like this?” If they won’t answer, that tells you something too.

Typical structures and terms

Here’s what credit fund deals look like in practice.

Warehouse facilities

The most common structure for fund capital.

Term	Typical Range	Notes
Advance rate	70-90%	80-90% for established originators, 70-85% for newer platforms
Pricing	SOFR + 300-500 bps	Asset class, originator quality, and advance rate all factor in
Commitment fee	25-50 bps	On undrawn amounts
Upfront/structuring fee	50-100 bps	Paid at closing
Term	2-3 years	Often with 1-year extensions at fund discretion
Minimum facility size	$25-50M	Below this, the setup costs don’t make sense

Worked Example: $100M consumer unsecured warehouse

85% advance rate
SOFR + 375 bps, 50 bps upfront, 25 bps undrawn fee
Assuming 90% average utilization over the term
Your effective all-in cost: approximately SOFR + 425 bps

Forward flow agreements

Whole loan purchases on a flow basis.

Term	Typical Range
Purchase price	99-101% of UPB
Volume commitment	Monthly or quarterly minimums
Term	12-24 months
Eligibility criteria	Tighter than your warehouse

Forward flows are simpler than warehouses (no SPV, no ongoing borrowing base) but require you to sell assets outright. You give up future economics on those loans.

Private securitization / term facility

Multi-tranche term deal, often with a credit fund taking mezzanine.

Example structure:

$200M term deal
Class A (80%): Bank takes senior at SOFR + 175 bps
Class B (12%): Credit fund takes mezz at SOFR + 550 bps
Residual (8%): Originator retains

The fund’s mezz position targets 12-14% gross return. The bank gets the senior at a spread that wouldn’t work for the fund. The originator keeps the residual upside.

Equity / residual investments

Some funds specialize in residual tranches or excess spread purchases.

Return expectations: 15-25%+ gross
Typically smaller positions ($10-50M)
More aligned with originator (both benefit from performance)
Often combined with debt from the same fund or affiliated vehicles

The investment process

Here’s what happens from first meeting to funded facility.

Stage 1: screening (2-4 weeks)

What happens:

Sign NDA
Deliver initial materials
Screening call with deal team

What they’re deciding: Is this in mandate? Does it clear basic hurdles? Is it worth spending diligence time?

What you need ready:

Executive summary (2-3 pages)
Sample loan tape (anonymized)
Static pool performance data (2-3 years by vintage)
Summary financials (audited if available)
Corporate deck / investor presentation

Go/no-go: At the end of screening, they’ll either schedule a deeper dive or politely pass.

Stage 2: preliminary diligence (4-6 weeks)

What happens:

Full data room access
Tape analytics (they’ll stratify your portfolio)
Management meetings (usually on-site)
Indicative term sheet (non-binding)

What they’re deciding: Is this a real deal? What are the risks? How should it be structured?

What you need ready:

Full loan tape with data dictionary
Complete static pool data by vintage and cohort
Audited financials (2-3 years)
Servicing policies and procedures
Compliance and licensing documentation
Sample loan files (10-20)

Milestone: Indicative term sheet. This is non-binding but signals serious intent.

Stage 3: credit committee (2-4 weeks)

What happens:

Internal credit memo written
IC presentation (you may be asked to present or join Q&A)
Preliminary IC approval
Commitment letter

What they’re deciding: Final go/no-go and approved terms.

Common IC questions:

How does this originator compare to others we’ve financed?
What happens if loss rates double?
What’s our recovery if the originator fails?
How does this fit our portfolio concentration?

Milestone: IC approval and commitment letter. Now you have a real deal.

Stage 4: documentation and closing (6-12 weeks)

What happens:

Legal engagement (both sides)
Document negotiation (indenture, SSA, purchase agreement, etc.)
Final diligence (loan file sampling, operational review)
Third-party reports (true sale opinion, UCC searches)
Account setup with trustee and account bank
Final IC blessing
Funding

What slows this down:

Legal markup cycles (each round takes a week)
Data quality issues discovered in final diligence
Account bank delays (surprisingly common)
Rating agency timeline (if rated tranches)
Competing priorities at the fund (other deals, fundraising)

Total timeline: 4-6 months from first meeting to funded facility for new relationships. Can compress to 2-3 months for repeat deals or follow-on facilities with an existing lender.

What to watch out for

Credit funds are sophisticated counterparties. They’ll optimize for their returns, which doesn’t always align with your interests.

Aggressive terms disguised as “market”

“Market” means different things to different people. A fund that’s done two ABF deals may quote terms that are aggressive compared to actual market. Always get comps.

Watch for:

Advance rate haircuts with no clear rationale
Overly tight triggers that will trip in normal volatility
Broad MAE clauses that give them unlimited discretion
Unilateral amendment or eligibility determination rights
Excessive cure periods for their benefit, short cure periods for yours

Ask: “Can you share where recent comparable deals priced? What are the advance rates and triggers on your other consumer warehouses?”

Fund lifecycle risk

A fund in late deployment may have less motivation to work through issues. A fund actively fundraising is distracted.

Questions to ask:

When does your fund close to new capital?
When do you expect to be fully deployed?
Are there other deals competing for the same allocation?

Key person dependency

If one person drives ABF at the fund, understand what happens if they leave.

Mitigation:

Build relationships with multiple people at the fund
Understand the IC sponsor’s tenure and role
Ask who else on the team has ABF expertise

Economic misalignment

If the fund only makes money on management fees (not carry), they’re incentivized to close deals, not necessarily good deals. Prefer funds with:

Significant GP commit (2%+)
Performance fees that align them with outcomes
Reputation stake in the asset class

Side letter requests

Funds sometimes request special terms via side letter. These can create complications:

MFN provisions may require sharing terms with other LPs
Special reporting or consent rights add operational burden
Economic side letters may affect your other financing relationships

Understand what they’re asking for and why before agreeing.

Relationship dynamics

ABF is a repeat-player market. How you behave in year one affects your options in year five.

The relationship is the asset

Funds talk to each other. Your reputation travels. A fund that has a bad experience with you will share that information. A fund that has a good experience may refer you to colleagues at other shops.

What this means:

Don’t surprise your lender. Communicate early on any performance issues.
Deliver clean, timely reporting. Late or messy reports signal operational problems.
Be responsive. If they ask for data, provide it promptly.
Honor your commitments. If you said you’d do something, do it.

Managing multiple fund relationships

Diversification across capital providers is healthy but adds complexity:

Different reporting templates and timelines
Different covenant structures and definitions
Different relationship managers with different expectations

Consider: one primary relationship plus one backup or participant. Don’t spread yourself so thin that no one feels like a priority.

When to switch funds

Loyalty has limits. Consider switching if:

Material degradation in terms on renewal
Fund is exiting ABF or the strategy
Better economics available elsewhere (but factor in switching costs: legal, time, relationship)
Relationship breakdown (rare but happens)

The graduation path

Many originators follow a predictable path:

Start with specialty finance fund: They’ll take the risk, they know ABF, they move fast
Build track record: 2-3 years of clean performance
Add bank capital: As senior tranche or parallel facility at tighter spreads
Eventually: Insurance capital, rated deals, public ABS

Some specialty finance funds explicitly position as “bridge to bank” and will help you make introductions when you’re ready.

Major credit fund players

This is not exhaustive, and fit depends on asset class, deal size, and structure type. But these names come up repeatedly in ABF.

Specialty finance focused

Waterfall Asset Management
Victory Park Capital
Castlelake
Monroe Capital
Atalaya Capital
Stellus Capital

Large private credit platforms

Ares Management
Apollo Global Management
Blue Owl Capital
HPS Investment Partners
Golub Capital
KKR Credit

Insurance-affiliated managers

BlackRock
PIMCO
Nuveen / TIAA
MetLife Investment Management
Prudential Private Capital

Opportunistic / multi-strategy

Elliott Management
Davidson Kempner
Cerberus
Avenue Capital

When fund capital works (and doesn’t)

Fund capital is the right choice when:

You’re an early-stage originator. Banks won’t touch you until you have scale and track record. Funds will take calculated risks on newer platforms.

Your asset class is new or esoteric. Funds have more flexibility in their mandates. They can do marketplace lending, litigation finance, or music royalties when banks can’t.

Speed matters. Funds can move faster than banks (though this varies). If you need capital in 90 days, a fund is more likely to hit that timeline.

You need a partner, not just a lender. Funds are often more willing to work through performance issues than banks, which may just pull the facility. This isn’t universal, but the dynamic tends that way.

Your structure is non-standard. Bespoke structures, participations, equity-like features: funds can get creative in ways banks can’t.

Bank capital is better when:

You have an established track record and proven asset class. Banks price senior risk tighter than funds (often 100-150 bps inside). If you qualify for bank capital, it’s cheaper.

Scale matters. Banks can provide larger commitments ($500M+) more easily than most funds.

Regulatory stability is important. Banks are less likely to exit the business entirely. Funds come and go with market cycles.

Insurance capital is better when:

You’re doing a rated deal with IG tranches. Insurance companies are the natural buyers of investment-grade ABS.

You want long-duration, match-funded capital. Insurance capital is patient by nature (matching long-dated liabilities).

Spread is the priority on senior tranches. Insurance can price inside credit funds on senior rated paper.

The hybrid approach

Many originators don’t choose one or the other. They use:

Credit fund for subordinate/mezzanine pieces
Bank for senior tranche
Or: start with fund warehouse, graduate to bank warehouse, add fund mezz/equity alongside

This optimizes cost across the capital structure while maintaining access to flexible capital.

Red flags

Multiple funds pass. If three specialty finance funds all pass, ask why. It’s usually originator quality, not the deal. Get the feedback and address it before approaching others.

Terms are dramatically better than competitors. If one fund’s terms are 100 bps inside everyone else, understand why. Are they desperate to deploy? Do they see the risk differently? There’s usually a reason.

You’re their only option. If a fund knows they’re your only path to capital, expect aggressive terms. Create competition whenever possible.

Key questions checklist

Use this when evaluating fund partners.

Fund Profile:

Where are you in your fund lifecycle?
What are your LP mandate constraints?
How many ABF deals have you closed in this asset class?
What’s your typical hold size?
Do you lead or participate?

Economics:

What’s your minimum return threshold?
Can you share where recent comparable deals priced?
What advance rates are you seeing on similar deals?

Process:

Who’s on the deal team and who’s the IC sponsor?
What’s your expected timeline from term sheet to close?
What are the three things most likely to kill this deal at IC?

Relationship:

What’s your typical approach when borrowers face performance issues?
How do you think about supporting borrowers toward graduation to bank capital?
What reporting format and frequency do you require?